Bill Texts: VA SB614 | 2024 | Regular Session
Bill Title: Xylazine; penalty for manufacturing, selling, etc., for human consumption.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Passed) 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0516) [SB614 Detail]
Spectrum: Partisan Bill (Republican 2-0)
Status: (Passed) 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0516) [SB614 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|---|---|---|---|
| Chaptered | 2024-04-04 | HTML/Text | Link | View |
| Enrolled | 2024-02-29 | HTML/Text | Link | View |
| Comm Sub | 2024-02-01 | HTML/Text | Link | View |
| Prefiled | 2024-01-10 | HTML/Text | Link | View |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|---|---|---|---|---|
| Substitute for SB614 S-Education and Health, Health Professions | 2024-01-26 | Proposed | Link | View |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|---|---|---|---|---|
| Fiscal Note/Analysis | Senate: Prefiled and ordered printed; offered 01/10/24 24104627D | 2024-01-12 | Link | View | |
| Fiscal Note/Analysis | Senate: Impact statement from DPB (SB614) | 2024-01-25 | Link | View | |
| Fiscal Note/Analysis | Senate: Impact statement from VCSC (SB614S1) | 2024-02-02 | Link | View | |
| Fiscal Note/Analysis | Senate: Impact statement from DPB (SB614S1) | 2024-02-05 | Link | View | |
| Fiscal Note/Analysis | Senate: Bill text as passed Senate and House (SB614ER) | 2024-02-29 | Link | View |
